X

CAH

Cardinal Health Inc (CAH) Cardinal Health report highlights cost savings and provider confidence in biosimilars

Cardinal Health Inc (NYSE: CAH) FY 2026 Other Release

Cardinal Health Inc (CAH) Dividend Update

Cardinal Health Inc (NYSE: CAH) Q1 2026 Dividend Update

Cardinal Health Inc (CAH) Sec Form 10Q

Cardinal Health Inc (NYSE: CAH) Sec Form 10Q

Cardinal Health Inc (CAH) Sec Form 8K

Cardinal Health Inc (NYSE: CAH) Sec Form 8K

Cardinal Health Inc (CAH) Q1 2022 Earnings Call Transcript

Cardinal Health Inc (NYSE: CAH) Q1 2022 Earnings Call dated Nov. 09, 2021 Corporate Participants: Kevin Moran — Vice President…

Cardinal Health Inc (CAH) Q2 2025 Earnings Call Transcript

Cardinal Health Inc (NYSE: CAH) Q2 2025 Earnings Call dated Jan. 30, 2025 Corporate Participants: Matt Sims — Vice President,…

Cardinal Health Inc (CAH) Q3 2025 Earnings Call Transcript

Cardinal Health Inc (NYSE: CAH) Q3 2025 Earnings Call dated May. 01, 2025 Corporate Participants: Matt Sims — Vice President,…

Cardinal Health Inc (CAH) Q4 2025 Earnings Call Transcript

Cardinal Health Inc (NYSE: CAH) Q4 2025 Earnings Call dated Aug. 12, 2025 Corporate Participants: Matt Sims — Vice President,…

Cardinal Health Inc (CAH) Q1 2026 Earnings Call Transcript

Cardinal Health Inc (NYSE: CAH) Q1 2026 Earnings Call dated Oct. 30, 2025 Corporate Participants: Matt Sims — Vice President,…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2024 results

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the…